1. Home
  2. RGEN vs AFRM Comparison

RGEN vs AFRM Comparison

Compare RGEN & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • AFRM
  • Stock Information
  • Founded
  • RGEN 1981
  • AFRM 2012
  • Country
  • RGEN United States
  • AFRM United States
  • Employees
  • RGEN N/A
  • AFRM N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • AFRM Business Services
  • Sector
  • RGEN Health Care
  • AFRM Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • AFRM Nasdaq
  • Market Cap
  • RGEN 6.5B
  • AFRM 21.3B
  • IPO Year
  • RGEN N/A
  • AFRM 2021
  • Fundamental
  • Price
  • RGEN $145.46
  • AFRM $69.98
  • Analyst Decision
  • RGEN Buy
  • AFRM Buy
  • Analyst Count
  • RGEN 11
  • AFRM 26
  • Target Price
  • RGEN $170.90
  • AFRM $85.64
  • AVG Volume (30 Days)
  • RGEN 1.1M
  • AFRM 5.2M
  • Earning Date
  • RGEN 10-28-2025
  • AFRM 11-06-2025
  • Dividend Yield
  • RGEN N/A
  • AFRM N/A
  • EPS Growth
  • RGEN N/A
  • AFRM N/A
  • EPS
  • RGEN 0.03
  • AFRM 0.15
  • Revenue
  • RGEN $707,890,000.00
  • AFRM $3,224,412,000.00
  • Revenue This Year
  • RGEN $16.79
  • AFRM $26.35
  • Revenue Next Year
  • RGEN $13.58
  • AFRM $23.86
  • P/E Ratio
  • RGEN $5,681.44
  • AFRM $450.25
  • Revenue Growth
  • RGEN 11.74
  • AFRM 38.80
  • 52 Week Low
  • RGEN $102.97
  • AFRM $30.90
  • 52 Week High
  • RGEN $182.52
  • AFRM $100.00
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 48.15
  • AFRM 41.47
  • Support Level
  • RGEN $144.18
  • AFRM $68.37
  • Resistance Level
  • RGEN $169.87
  • AFRM $78.95
  • Average True Range (ATR)
  • RGEN 6.27
  • AFRM 3.46
  • MACD
  • RGEN -2.31
  • AFRM -0.03
  • Stochastic Oscillator
  • RGEN 4.98
  • AFRM 21.73

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About AFRM Affirm Holdings Inc.

Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.

Share on Social Networks: